Delivery Order SPE2DB22D1202-SPE2DB24FVFV5
Award Date
7/3/24
Potential Completion Date
7/5/24
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,870.81, is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product, with a completion date of November 8, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,187.36 delivery order contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,713.56, is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, and has an ultimate completion date of October 30, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $11,661.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a completion date of June 27, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated with any set-aside requirements, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,731.36, is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of November 1, 2024. The contract does not have a set-aside designation, indicating it was competed openly....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,998.24, is a Firm Fixed Price Delivery Order for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication. The contract has an ultimate completion date of July 1, 2024 and was awarded on June 28, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,066.69 firm fixed-price delivery order is for fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of February 18, 2025 and was awarded on February 14, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,131.27, is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award, valued at $1,213.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, and has an ultimate completion date of January 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,506.59, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product. The contract has a completion date of February 13, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and...